The global medical foods market size is expected to reach USD 27.20 billion by 2025, registering a CAGR of 6.7% from 2019 to 2025 Rising geriatric population and increasing prevalence of chronic diseases are among the key factors driving the market. According to the WHO estimates published in February 2018, the population aged 60 years and above is expected to increase from 12% in 2015 to 22% by 2050. Non-communicable diseases impose a high economic burden on health systems globally. According to a study conducted by the researchers from University of Liège, Belgium, the population suffering from sarcopenia in Europe is expected to increase from 11.1% in 2016 to 12.9% in 2045.
Medical foods help treat and prevent age-related sarcopenia.Thus, the demand for medical foods in the management of chronic conditions, such as sarcopenia, is expected to augment the market development.
Moreover, various public and private initiatives in the field of clinical nutrition is projected to boost the market further.A number of manufacturers are extending their capabilities in the sports nutrition market with various strategic initiatives, such as M&A and new product launches, to fulfill the escalating demand.
For instance, in May 2016, Hormel Foods introduced HORMEL VITAL CUISINE, a range of Ready-to-Eat (RTE) meals, whey protein powders, and nutritional shakes. This product line was specially designed to meet the nutritional requirements of cancer patients.
Latest posts by Ivy Heffernan (see all)
- Lower Cholesterol at Home – Diet Tips - August 21, 2019
- Fintech Fundraising Continues To Break Records at $120 Billion - August 21, 2019
- Qatar Construction Increases With Permit Issuance Up 51% - August 21, 2019